BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17703017)

  • 1. High Court upholds NICE decision to limit treatments for Alzheimer's disease.
    Dyer O
    BMJ; 2007 Aug; 335(7615):319. PubMed ID: 17703017
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE insiders criticise Alzheimer's drug decision.
    Gould M
    Health Serv J; 2006 Oct; 116(6028):8. PubMed ID: 17086921
    [No Abstract]   [Full Text] [Related]  

  • 3. NICE's cost effectiveness threshold.
    Appleby J; Devlin N; Parkin D
    BMJ; 2007 Aug; 335(7616):358-9. PubMed ID: 17717337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appeal Court rules that NICE procedure was unfair.
    Dyer C
    BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467392
    [No Abstract]   [Full Text] [Related]  

  • 5. Dementia, postcode prescribing and NICE.
    Jones RW
    Age Ageing; 2004 Jul; 33(4):331-2. PubMed ID: 15226104
    [No Abstract]   [Full Text] [Related]  

  • 6. Lawyers claim "concession" over drug prescribing for Alzheimer's disease.
    Dyer C
    BMJ; 2007 Jul; 335(7609):11. PubMed ID: 17615199
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness research: NICE for the NHS, but false starts for the US.
    Lyles A
    Clin Ther; 2008 Sep; 30(9):1702-3. PubMed ID: 18840376
    [No Abstract]   [Full Text] [Related]  

  • 9. The national drug policy.
    Philipp J Nurs; 1988; 58(3):18-21. PubMed ID: 3241824
    [No Abstract]   [Full Text] [Related]  

  • 10. [British court supports limited use of drugs against dementia].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2418. PubMed ID: 17944011
    [No Abstract]   [Full Text] [Related]  

  • 11. National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer's disease drugs continues.
    Whitehouse PJ
    J Alzheimers Dis; 2008 Apr; 13(3):239-40. PubMed ID: 18567175
    [No Abstract]   [Full Text] [Related]  

  • 12. Not so NICE. A proposal from the National Institute for Clinical Excellence to withdraw treatments for Alzheimer's disease from the NHS has left support groups reeling.
    Heath H
    Nurs Older People; 2005 Apr; 17(2):8. PubMed ID: 15835500
    [No Abstract]   [Full Text] [Related]  

  • 13. Nurses warn Alzheimer's drugs ban will lead to more sedation.
    Kenny C
    Nurs Times; 2006 Jan 31-Feb 6; 102(5):6. PubMed ID: 16475568
    [No Abstract]   [Full Text] [Related]  

  • 14. Court upholds Gillick competence in puberty blockers case.
    Thornton J
    Lancet; 2021 Oct; 398(10307):1205-1206. PubMed ID: 34563272
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental health legislation and decision making capacity: autonomy in Alzheimer's disease is ignored and neglected.
    Stewart R
    BMJ; 2006 Jan; 332(7533):118-9. PubMed ID: 16410593
    [No Abstract]   [Full Text] [Related]  

  • 16. Alzheimer's disease research in the context of the national plan to address Alzheimer's disease.
    Snyder HM; Hendrix J; Bain LJ; Carrillo MC
    Mol Aspects Med; 2015; 43-44():16-24. PubMed ID: 26096321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NICE reiterates that people with mild Alzheimer's disease should not get drug treatment.
    Dyer C
    BMJ; 2009 Jun; 338():b2413. PubMed ID: 19525311
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 19. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 20. NICE faces legal challenge over Alzheimer's drug.
    Dyer C
    BMJ; 2007 Mar; 334(7595):654-5. PubMed ID: 17395920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.